How to startup funding works?

Startup funding: what it is (and what it isn’t)

Startup funding is how a new company pays for building and selling a product before it reliably generates enough cash from customers. The “funding” can come from customers (revenue), founders (savings), investors (equity), or lenders (debt). Each source has a different cost.

Two clarifications that save a lot of confusion:

• Funding is not success. It’s a tool to buy time and speed. A funded startup can still fail if it can’t find a repeatable way to acquire customers.
• Funding is not one event. It’s usually a sequence of rounds tied to milestones (e.g., prototype → early sales → scalable growth).

For STEM/medical founders, the trap is treating fundraising like a grant application. Investors are usually not paying for “interesting science.” They’re paying for risk reduction toward a big outcome: a company that can grow revenue and eventually return capital (often via acquisition or IPO).

The main funding paths (and when each makes sense)

Most startups combine multiple paths over time. Here are the common ones, in plain language.

1) Bootstrapping (self-funding + revenue)

Bootstrapping means you fund the company with your own money and/or customer revenue. The “cost” is slower speed and personal financial risk, but you keep control and avoid dilution (explained below).

Best when: you can reach paying customers quickly (often B2B software, services, or a narrow wedge product).

2) Friends & family

Early money from people who trust you. It’s emotionally high-stakes. Use clear paperwork and avoid ambiguous promises.

Best when: you need a small amount to reach a concrete milestone (e.g., MVP, pilot, regulatory plan) and you can’t yet attract professional investors.

3) Angel investors

Angels are individuals investing their own money. They often invest earlier than venture capital and may be more flexible on terms.

Best when: you have early evidence (prototype, LOIs, pilot users, early revenue) and need capital to validate the business model.

4) Venture capital (VC)

Venture capital is money from a fund that invests in high-growth companies aiming for large outcomes. VCs typically look for scalable growth and a market big enough to produce a large return.

Best when: you can plausibly build a large company and capital meaningfully increases speed (hiring, go-to-market, regulatory execution, manufacturing scale, etc.).

5) Non-dilutive funding (grants, prizes, partnerships)

Non-dilutive means you don’t give up ownership. Examples include grants, competitions, and some strategic partnerships. Availability and fit vary widely by country and sector.

Best when: your work aligns with a program’s goals and you can handle the application/reporting overhead without stalling customer discovery.

6) Debt (loans, lines of credit, venture debt)

Debt must be repaid (usually with interest). It’s often hard to get pre-revenue unless you have collateral, strong contracts, or a track record. Venture debt is a specialized loan for VC-backed startups; it can extend runway but adds repayment risk.

Best when: you have predictable cash flows (or strong contracts) and want to avoid additional dilution.

Funding stages: pre-seed → seed → Series A (and what changes)

Round names are shorthand for maturity. Amounts vary by geography and sector, so focus on what each stage is supposed to accomplish.

• Pre-seed: Prove the problem is real and you can build a credible solution. Typical milestones: customer interviews, prototype, early pilots, initial pricing hypothesis.
• Seed: Prove you can sell it repeatedly (early go-to-market). Milestones: first meaningful revenue, retention signals, repeatable sales motion, clear ICP (ideal customer profile).
• Series A: Prove you can scale what works. Milestones: strong growth, efficient acquisition, expanding team, predictable pipeline, clear unit economics (explained below).

Investors at each stage are underwriting different risks. Early rounds are about product risk and market risk. Later rounds are about scaling risk and execution risk.

How investors think: dilution, valuation, runway, and unit economics

Fundraising becomes much less mysterious once you understand four concepts.

Dilution (what you give up)

Dilution is the reduction in your ownership percentage when you issue new shares to investors or employees (via an option pool). Example: if you own 100% and sell 20% to raise money, you now own 80%. If you later sell another 20% of the company, your 80% gets diluted again (you’d own 64% if the new 20% is issued on top of the existing shares).

Dilution isn’t automatically bad. The question is whether the capital increases the company’s value enough to make your smaller percentage worth more.

Valuation (the price of ownership)

Valuation is the implied value of the company. In early stages it’s often driven by comparable deals, team credibility, traction, and market size more than spreadsheets.

Two terms you’ll hear:

• Pre-money valuation: value before the new investment.
• Post-money valuation: value after the investment (pre-money + new money).

Runway and burn (how long you can operate)

Burn is how much cash you spend per month net of revenue. Runway is how many months you can operate before cash hits zero.

Simple math:

• Monthly burn = monthly expenses − monthly gross profit
• Runway (months) = cash in bank ÷ monthly burn

Investors like to see you raise enough to reach the next milestone with buffer. Many founders target something like 12–18 months of runway, but it varies with sales cycles and regulatory timelines.

Unit economics (do you make money per customer?)

Unit economics means the profitability of one “unit” (usually a customer). Common metrics:

• CAC (Customer Acquisition Cost): what it costs to acquire a customer (sales + marketing).
• LTV (Lifetime Value): gross profit you expect from a customer over time.
• Payback period: how long it takes to earn back CAC from gross profit.

Even if you’re early, investors want to see that the model could work: pricing power, willingness to pay, and a path to acquiring customers without costs exploding.

Common deal structures: priced equity vs SAFE/convertible notes

Early-stage rounds often use simpler instruments to avoid negotiating a full valuation too soon.

Priced equity round

A priced round sets a valuation now and sells shares at that price. It’s more paperwork and legal cost, but it’s clear.

SAFE (Simple Agreement for Future Equity)

A SAFE is an agreement that converts into equity in a future priced round. It usually includes:

• Valuation cap: a maximum valuation at which the SAFE converts (rewards early risk).
• Discount: converts at a discount to the next round’s price (sometimes used instead of a cap).

SAFEs are popular because they’re fast. The tradeoff is that founders can accidentally stack too many SAFEs and create surprise dilution later.

Convertible note

A convertible note is similar to a SAFE but is technically debt: it has interest and a maturity date, and it converts later. It can add pressure if the next round takes longer than expected.

Regardless of instrument, the core question is the same: how much ownership are you effectively giving up to get enough runway to hit the next value-creating milestone?

What to do next

1. Define your next milestone in one sentence (e.g., “10 paying customers in one ICP” or “pilot results that prove X outcome”) and estimate the time and cost to reach it.
2. Build a 12–18 month cash plan (headcount, contractors, tools, regulatory/clinical costs if relevant) and compute burn + runway. Use /finances.
3. Choose the least expensive capital that can realistically get you to the milestone (revenue first if possible; otherwise angels/seed; consider non-dilutive if it won’t stall customer work).
4. Prepare a tight investor narrative: problem, why now, your unfair advantage, traction, business model, and what the round buys you. If you want feedback, use /roast.
5. Map your market and competitors so you can explain differentiation without hand-waving. Use /Competitor_study.